Company intelligence / Profile preview
Septalyst Lifesciences
Thane, Maharashtra, Indiaseptalyst.com ↗
- Ownership
- Private
- Employees
- ~350
- Development stage
- Commercial
01
Overview
Septalyst Lifesciences is a Mumbai-based super-specialty pharmaceutical company established in 2010. It is recognized among the top five companies in Indian nephrology and is a leading player in the CNS segment. The company has developed several branded products for chronic kidney disease, renal transplantation, neuropsychiatric conditions, and critical care. Its R&D efforts have resulted in patented products like Kobacar for stroke patients and market-leading brands such as Synprotik for renal nutrition. The company operates with over 350 employees across India.
- Therapeutic areas
- NeurologyOtherPsychiatryNephrology
- Modalities
- Small molecules (based on product types such as tablets, capsules, injections)
- Industry
- Biotech
02
Drug pipeline
19 assets18 more assets in the full pipeline.
Beyond the preview
Go deeper on Septalyst Lifesciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Septalyst Lifesciences.